Key result
Among older adults in specialist mental health services, 74% had persistent levels of anxiety symptoms over 33 months, and baseline anxiety severity did not predict cognitive decline or mortality.
Why the study?
Anxiety symptoms are common in older age and proposed risk factors for cognitive impairment and mortality, but whether they persist in older adults with mental disorders and predict cognitive decline or mortality was unclear.
Are anxiety symptoms persistent in older adults with a mental health diagnosis, and does severity predict cognitive decline and mortality?
Cohort (n=201)
Are anxiety symptoms persistent in older adults with a mental health diagnosis, and does severity predict cognitive decline and mortality?
In older adults in specialist mental health services, anxiety symptom levels are persistent over time but do not predict future cognitive decline or mortality.
Baseline anxiety should not yet inform prognosis in older adults; leaves open whether persistence affects other outcomes.
OBJECTIVE: Anxiety symptoms are common in old age and have been suggested as risk factors for development of cognitive impairment and mortality. The objective of the present study was to investigate whether anxiety symptoms among older adults with a mental health diagnosis are persistent, and severity of anxiety predicts cognitive decline and mortality. METHODS: We collected data from 201 patients referred to specialist mental health service in a department of geriatric psychiatry. Of these, 150 were reexamined after 33 months, while 51 patients died before follow-up. Mean age (SD) at baseline among the patients that were reexamined was 73.4 (7.3) years, and 67% were women. The Geriatric Anxiety Inventory (GAI) was used to measure anxiety symptoms at baseline and follow-up. We investigated whether higher GAI scores at baseline were associated with persistence of anxiety. Associations with cognitive decline or mortality were also explored. The associations were estimated by use of trajectory analysis and regression models. RESULTS: Seventy-four percentages had the same level of anxiety symptoms, and 29% had a high level of anxiety at baseline and follow-up. GAI score at baseline was not associated with cognitive decline or mortality at 33-month follow-up. CONCLUSION: In a longitudinal study of anxiety symptoms among older adults in specialist mental health services, we demonstrate persistent high or low levels of anxiety symptoms. Anxiety trajectories over time were not predicted by patient characteristics. Also the level of anxiety cannot be used as predictor for future cognitive decline or mortality in a clinical population.
No takes yet. Share an insight, caveat, or question.
Bendixen et al. (2019) conducted a cohort in Mental disorder with anxiety symptoms (n=201). Anxiety symptoms (GAI score) was evaluated on Persistence of anxiety symptoms. Among older adults in specialist mental health services, 74% had persistent levels of anxiety symptoms over 33 months, and baseline anxiety severity did not predict cognitive decline or mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: